LP
ONC

LMR Partners’s BeOne Medicines Ltd ONC Stock Holding History

LMR Partners’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-78,369
Closed -$19M – 1706
2025
Q2 		$19M Buy
78,369
+53,711
+218% +$13.2M 0.14% 161
2025
Q1 		$6.71M Buy
24,658
+22,373
+979% +$5.23M 0.06% 334
2024
Q4 		$422K Sell
2,285
-4,553
-67% -$930K ﹤0.01% 857
2024
Q3 		$1.54M Buy
+6,838
New +$1.23M 0.01% 665
2024
Q2 		– Sell
-18,954
Closed -$2.96M – 1356
2024
Q1 		$2.96M Buy
18,954
+15,520
+452% +$2.5M 0.03% 459
2023
Q4 		$619K Sell
3,434
-10,447
-75% -$1.89M 0.01% 630
2023
Q3 		$2.5M Buy
+13,881
New +$2.75M 0.03% 367
2022
Q3 		– Sell
-13,108
Closed -$2.12M – 1321
2022
Q2 		$2.12M Buy
+13,108
New +$2.05M 0.04% 507
2022
Q1 		– Sell
-5,931
Closed -$1.61M – 1372
2021
Q4 		$1.61M Sell
5,931
-4,123
-41% -$1.39M 0.02% 544
2021
Q3 		$3.65M Buy
+10,054
New +$3.29M 0.04% 324
2020
Q2 		– Sell
-12,159
Closed -$1.52M – 649
2020
Q1 		$1.52M Hold
12,159
– – 0.07% 111
2019
Q4 		$2.02K Buy
12,159
+6,331
+109% +$1.05M ﹤0.01% 128
2019
Q3 		$714K Buy
+5,828
New +$774K 0.04% 219

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LMR Partners's ONC Position: Q3 2025 in Review

LMR Partners sold out of BeOne Medicines Ltd (ONC) in Q3 2025, closing a stake of 78,369 shares — an estimated $19M sold.

LMR Partners first reported a position in ONC in Q3 2019 and held it in 13 quarters. The position peaked at $19M in Q2 2025. 266 funds tracked by Wall St. Rank hold ONC as of Q3 2025.

  • LMR Partners reported no remaining BeOne Medicines Ltd position as of Q3 2025 after selling out during the quarter.
  • LMR Partners sold 78,369 BeOne Medicines Ltd shares in Q3 2025, an estimated $19M.
  • LMR Partners first reported a position in BeOne Medicines Ltd in Q3 2019 and held it in 13 quarters.
  • LMR Partners's BeOne Medicines Ltd position peaked at $19M in Q2 2025.
  • 266 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2025.

Based on LMR Partners's 13F filing for Q3 2025, filed 14 Nov 2025.